333 related articles for article (PubMed ID: 24055766)
1. Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers.
Huang TD; Poirel L; Bogaerts P; Berhin C; Nordmann P; Glupczynski Y
J Antimicrob Chemother; 2014 Feb; 69(2):445-50. PubMed ID: 24055766
[TBL] [Abstract][Full Text] [Related]
2. A disc diffusion assay for detection of class A, B and OXA-48 carbapenemases in Enterobacteriaceae using phenyl boronic acid, dipicolinic acid and temocillin.
van Dijk K; Voets GM; Scharringa J; Voskuil S; Fluit AC; Rottier WC; Leverstein-Van Hall MA; Cohen Stuart JW
Clin Microbiol Infect; 2014 Apr; 20(4):345-9. PubMed ID: 23927659
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of an algorithm for the phenotypic screening of carbapenemase-producing Enterobacteriaceae.
Dortet L; Cuzon G; Plésiat P; Naas T
J Antimicrob Chemother; 2016 Jan; 71(1):135-40. PubMed ID: 26462984
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium.
Huang TD; Berhin C; Bogaerts P; Glupczynski Y;
J Antimicrob Chemother; 2013 Aug; 68(8):1832-7. PubMed ID: 23557926
[TBL] [Abstract][Full Text] [Related]
5. Development of an algorithm for phenotypic screening of carbapenemase-producing Enterobacteriaceae in the routine laboratory.
Robert J; Pantel A; Merens A; Meiller E; Lavigne JP; Nicolas-Chanoine MH;
BMC Infect Dis; 2017 Jan; 17(1):78. PubMed ID: 28095794
[TBL] [Abstract][Full Text] [Related]
6. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
Polsfuss S; Bloemberg GV; Giger J; Meyer V; Hombach M
J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269
[TBL] [Abstract][Full Text] [Related]
7. A combined disc method with resazurin agar plate assay for early phenotypic screening of KPC, MBL and OXA-48 carbapenemases among Enterobacteriaceae.
Teethaisong Y; Eumkeb G; Nakouti I; Evans K; Hobbs G
J Appl Microbiol; 2016 Aug; 121(2):408-14. PubMed ID: 27253907
[TBL] [Abstract][Full Text] [Related]
8. Comparison of disk diffusion, Etest and VITEK2 for detection of carbapenemase-producing Klebsiella pneumoniae with the EUCAST and CLSI breakpoint systems.
Vading M; Samuelsen Ø; Haldorsen B; Sundsfjord AS; Giske CG
Clin Microbiol Infect; 2011 May; 17(5):668-74. PubMed ID: 20649801
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Carbapenem Detection Set™ for the detection and characterization of carbapenemase-producing Enterobacteriaceae.
Dortet L; Bernabeu S; Gonzalez C; Naas T
Diagn Microbiol Infect Dis; 2018 Jul; 91(3):220-225. PubMed ID: 29548525
[TBL] [Abstract][Full Text] [Related]
10. Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study.
Haldorsen B; Giske CG; Hansen DS; Helgason KO; Kahlmeter G; Löhr IH; Matuschek E; Österblad M; Rantakokko-Jalava K; Wang M; Småbrekke L; Samuelsen Ø; Sundsfjord A;
J Antimicrob Chemother; 2018 Oct; 73(10):2738-2747. PubMed ID: 30053113
[TBL] [Abstract][Full Text] [Related]
11. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.
Livermore DM; Warner M; Mushtaq S; Doumith M; Zhang J; Woodford N
Int J Antimicrob Agents; 2011 May; 37(5):415-9. PubMed ID: 21429716
[TBL] [Abstract][Full Text] [Related]
12. Use of faropenem as an indicator of carbapenemase activity in the Enterobacteriaceae.
Day KM; Pike R; Winstanley TG; Lanyon C; Cummings SP; Raza MW; Woodford N; Perry JD
J Clin Microbiol; 2013 Jun; 51(6):1881-6. PubMed ID: 23576544
[TBL] [Abstract][Full Text] [Related]
13. Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem.
Oteo J; Ortega A; Bartolomé R; Bou G; Conejo C; Fernández-Martínez M; González-López JJ; Martínez-García L; Martínez-Martínez L; Merino M; Miró E; Mora M; Navarro F; Oliver A; Pascual Á; Rodríguez-Baño J; Ruiz-Carrascoso G; Ruiz-Garbajosa P; Zamorano L; Bautista V; Pérez-Vázquez M; Campos J;
Antimicrob Agents Chemother; 2015; 59(6):3406-12. PubMed ID: 25824224
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of carbapenemase screening and confirmation tests with Enterobacteriaceae and development of a practical diagnostic algorithm.
Maurer FP; Castelberg C; Quiblier C; Bloemberg GV; Hombach M
J Clin Microbiol; 2015 Jan; 53(1):95-104. PubMed ID: 25355766
[TBL] [Abstract][Full Text] [Related]
15. Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015.
Huang TD; Bogaerts P; Berhin C; Hoebeke M; Bauraing C; Glupczynski Y;
Euro Surveill; 2017 May; 22(19):. PubMed ID: 28537547
[TBL] [Abstract][Full Text] [Related]
16. What Is the Appropriate Meropenem MIC for Screening of Carbapenemase-Producing Enterobacteriaceae in Low-Prevalence Settings?
Fattouh R; Tijet N; McGeer A; Poutanen SM; Melano RG; Patel SN
Antimicrob Agents Chemother; 2015 Dec; 60(3):1556-9. PubMed ID: 26711746
[TBL] [Abstract][Full Text] [Related]
17. Temocillin and meropenem to discriminate resistance mechanisms leading to decreased carbapenem susceptibility with focus on OXA-48 in Enterobacteriaceae.
Hartl R; Widhalm S; Kerschner H; Apfalter P
Clin Microbiol Infect; 2013 May; 19(5):E230-2. PubMed ID: 23397897
[TBL] [Abstract][Full Text] [Related]
18. A simple phenotypic method for the differentiation of metallo-beta-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates.
Tsakris A; Poulou A; Pournaras S; Voulgari E; Vrioni G; Themeli-Digalaki K; Petropoulou D; Sofianou D
J Antimicrob Chemother; 2010 Aug; 65(8):1664-71. PubMed ID: 20542902
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a new phenotypic OXA-48 disk test for differentiation of OXA-48 carbapenemase-producing Enterobacteriaceae clinical isolates.
Tsakris A; Poulou A; Bogaerts P; Dimitroulia E; Pournaras S; Glupczynski Y
J Clin Microbiol; 2015 Apr; 53(4):1245-51. PubMed ID: 25653401
[TBL] [Abstract][Full Text] [Related]
20. Combined use of the modified Hodge test and carbapenemase inhibition test for detection of carbapenemase-producing Enterobacteriaceae and metallo-β-lactamase-producing Pseudomonas spp.
Song W; Hong SG; Yong D; Jeong SH; Kim HS; Kim HS; Kim JS; Bae IK
Ann Lab Med; 2015 Mar; 35(2):212-9. PubMed ID: 25729723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
